206 results on '"Appella E"'
Search Results
2. A Structural Model for the P53 Complex with DNA Response Elements: Implications for P53 Function and Future Research Directions
3. The Role of Structure in Complexes Between the p53 DNA Binding Domain and DNA Response Elements
4. Analysis of the structure of naturally processed peptides bound by Class I and Class II major histocompatibility complex molecules
5. The Human DNA-Activated Protein Kinase, DNA-PK: Substrate Specificity
6. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein
7. The Role of HSP90 in Tumor Specific Immunity
8. Zinc Fingers Involved in MHC Class I Gene Regulation: Use of Synthetic Peptides for Structural Analysis
9. Cloned Trans-Acting Factors that Bind to the Regulatory Elements of the Major Histocompatibility Complex Class I Gene
10. The human DNA-activated protein kinase, DNA-PK: Substrate specificity
11. Characterization of the p300 Taz2-p53 TAD2 Complex and Comparison with the p300 Taz2-p53 TAD1 Complex
12. Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells
13. Mapping of Antigen Epitopes Interacting with Class II MHC Products and with the Antigen Receptor of T Lymphocytes
14. Expression of T-Cell Receptor by a Mouse Monoclonal Antigen-Specific Suppressor T-Cell Line
15. The Receptor-Binding Sequence of Urokinase
16. Effects of mutations on tetramer formation of tumor suppressor protein p53
17. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
18. p53 N-terminal phosphorylation: a defining layer of complex regulation
19. Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with p53K382me1
20. ChemInform Abstract: Chemical Synthesis and Applications of Phosphopeptides
21. Structural Basis for the Regulation of p53 Function by p300
22. PML enhances the regulation of p53 by CK1 in response to DNA damage
23. Large CDR3a loop alteration as a function of MHC mutation
24. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
25. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
26. Human PMEL17 is sorted to Melanosomes by the adaptor protein complexes 1 and 2.
27. Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1
28. CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
29. CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
30. The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation
31. Meeting report
32. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor.
33. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue.
34. Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor.
35. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.
36. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.
37. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
38. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity
39. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).
40. Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.
41. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.
42. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation.
43. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.
44. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
45. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
46. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
47. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.
48. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.
49. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.
50. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.